Vesalius Ventures

Vesalius Ventures is a Houston, Texas-based venture capital firm founded in 2002, dedicated to accelerating the future of medicine by investing in early- to mid-stage healthcare technologies. It began as a VC accelerator focused on medical informatics and telemedicine, working closely with management teams and entrepreneurs, and has since grown into a diversified firm targeting large but unmet market needs, compelling technologies and superior companies. Beyond core digital health and medical informatics, its interests span information technology, telecommunications and energy. The firm operates through several entities: Vesalius Ventures Accelerator, Vesalius Capital Group, Vesalius Health Advisors and Vesalius International, supporting the development and commercialization of advanced technologies, generally as a co-investor. It was established through investments from three venture and corporate partners, Vanguard Ventures, Fremont Ventures and Guidant Corporation, now Boston Scientific, and was joined a year later by Sevin Rosen Funds. The firm is led by Dr. Bernard A. Harris Jr., CEO and Managing Partner, a former NASA astronaut and the first African American to walk in space, who is also a fellow of the American Telemedicine Association and previously worked with the $500M early-stage firm Vanguard Ventures. Portfolio themes include mobile cardiac telemetry, FDA-cleared medication-free treatment for panic disorder and PTSD, sepsis detection and contact-free post-acute biosensors such as Prevenir Health. Notable historical investments include Health Hero Network and LifeOnKey. The firm runs a small, focused team. By pairing capital with deep healthcare and telemedicine expertise, Vesalius Ventures backs early- to mid-stage medical-technology companies addressing large unmet needs.